National Health Investors (NHI) FY2016 results: revenue $248 million, up 8.5% on the year
National Health Investors Inc. (NHI) reported revenue of $248 million for fiscal 2016, the year ended 31 December 2016, up 8.5% on the year before. Net income was $152 million, up 1.8%, and diluted earnings per share $3.87. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2017.
Revenue
$248 million
+8.5% on the year
FY2009FY2016
Operating margin
47.8%
65.6% a year earlier
FY2009FY2016
Net income
$152 million
+1.8% on the year
FY2009FY2016
Diluted EPS
$3.87
-2.0% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
248
229
178
+8.5%
Operating income
119
150
103
-21.0%
Operating margin
47.8%
65.6%
58.1%
Interest expense
43.1
37.6
26.4
+14.6%
Pre-tax income
119
127
103
-6.3%
Income tax
0.9
-0.6
0.1
Effective tax rate
0.7%
-0.5%
0.1%
Net income
152
149
102
+1.8%
Net margin
61.0%
65.0%
57.2%
Diluted EPS
$3.87
$3.95
$3.04
-2.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
177
164
126
+7.4%
Capital expenditure
395
124
533
+218.0%
Free cash flow
-218
40.3
-407
Free cash flow margin
-87.8%
17.6%
-229.3%
Cash from investing
-330
-136
-540
Cash from financing
144
-18.1
406
Share-based compensation
1.7
2.1
2.0
-18.8%
Dividends paid
138
125
101
+10.9%
Dividend per share
$3.60
$3.40
$3.08
+5.9%
Diluted shares, weighted
39m
38m
33m
+4.0%
Shares outstanding at period end
40m
38m
37m
+3.8%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
1,210
1,133
1,040
+6.7%
Non-controlling interest
0.0
9.2
10.0
Debt
1,116
914
863
+22.0%
Other liabilities
78.1
76.3
70.3
+2.3%
Total liabilities and equity
2,404
2,133
1,983
+12.7%
Fixed assets
2,160
1,837
1,777
+17.6%
Loans
133
134
63.6
-0.2%
Cash and equivalents
4.6
13.1
3.1
-64.6%
Receivables
9.2
3.3
3.8
+182.9%
Other assets
96.5
146
136
-34.1%
Total assets
2,404
2,133
1,983
+12.7%
10-K for the year ended 31 December 2016, filed 17 February 2017: the filing.